Your browser doesn't support javascript.
loading
Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial.
Bidard, François-Clément; Jacot, William; Kiavue, Nicolas; Dureau, Sylvain; Kadi, Amir; Brain, Etienne; Bachelot, Thomas; Bourgeois, Hugues; Gonçalves, Anthony; Ladoire, Sylvain; Naman, Hervé; Dalenc, Florence; Gligorov, Joseph; Espié, Marc; Emile, George; Ferrero, Jean-Marc; Loirat, Delphine; Frank, Sophie; Cabel, Luc; Diéras, Véronique; Cayrefourcq, Laure; Simondi, Cécile; Berger, Frédérique; Alix-Panabières, Catherine; Pierga, Jean-Yves.
Afiliación
  • Bidard FC; Department of Medical Oncology, Institut Curie, UVSQ and Paris-Saclay University, Saint-Cloud, France.
  • Jacot W; INSERM Center of Clinical Investigations in Biotherapies of Cancer (CIC-BT) 1428, Paris, France.
  • Kiavue N; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Montpellier University, Montpellier, France.
  • Dureau S; Department of Medical Oncology, Institut Curie, UVSQ and Paris-Saclay University, Saint-Cloud, France.
  • Kadi A; Biometry Unit, Institut Curie, PSL Research University, Paris, France.
  • Brain E; Biometry Unit, Institut Curie, PSL Research University, Paris, France.
  • Bachelot T; Department of Medical Oncology, Institut Curie, UVSQ and Paris-Saclay University, Saint-Cloud, France.
  • Bourgeois H; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Gonçalves A; Department of Medical Oncology, Victor Hugo Clinic, Le Mans, France.
  • Ladoire S; Department of Medical Oncology, Institut Paoli-Calmettes, CRCM, Aix-Marseille University, Marseille, France.
  • Naman H; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.
  • Dalenc F; Department of Medical Oncology, Centre Azuréen de Cancérologie, Mougins, France.
  • Gligorov J; Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France.
  • Espié M; Department of Medical Oncology, Hôpital Tenon, Sorbonne Université, Paris, France.
  • Emile G; Department of Medical Oncology, Hôpital Saint-Louis, Paris, France.
  • Ferrero JM; Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • Loirat D; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Frank S; Department of Medical Oncology, Institut Curie, Université de Paris, Paris, France.
  • Cabel L; Department of Medical Oncology, Institut Curie, Université de Paris, Paris, France.
  • Diéras V; Department of Medical Oncology, Institut Curie, UVSQ and Paris-Saclay University, Saint-Cloud, France.
  • Cayrefourcq L; Formerly with Department of Medical Oncology, Institut Curie, Paris, France.
  • Simondi C; Now with Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Berger F; Laboratory of Rare Human Circulating Cells, University Medical Center of Montpellier, EA 2415, Montpellier University, Montpellier, France.
  • Alix-Panabières C; Clinical Research Department, Institut Curie, PSL Research University, Paris, France.
  • Pierga JY; Biometry Unit, Institut Curie, PSL Research University, Paris, France.
JAMA Oncol ; 7(1): 34-41, 2021 Jan 01.
Article en En | MEDLINE | ID: mdl-33151266
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Células Neoplásicas Circulantes Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: JAMA Oncol Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Células Neoplásicas Circulantes Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: JAMA Oncol Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos